vs

Side-by-side financial comparison of Cytosorbents Corp (CTSO) and FVCBankcorp, Inc. (FVCB). Click either name above to swap in a different company.

FVCBankcorp, Inc. is the larger business by last-quarter revenue ($16.9M vs $9.2M, roughly 1.8× Cytosorbents Corp). On growth, FVCBankcorp, Inc. posted the faster year-over-year revenue change (4377.5% vs 0.9%). FVCBankcorp, Inc. produced more free cash flow last quarter ($23.8M vs $-4.9M). Over the past eight quarters, FVCBankcorp, Inc.'s revenue compounded faster (586.6% CAGR vs 1.3%).

CytoSorbents Corporation is a publicly traded company located in Princeton, New Jersey.

FVCBankcorp, Inc. is a Virginia-based U.S. bank holding company operating FVCbank, a community-focused financial institution. It provides a full range of personal and commercial banking products including deposit accounts, business and personal loans, mortgage services, and wealth management solutions, serving SMEs, professionals and individual consumers across the Mid-Atlantic region.

CTSO vs FVCB — Head-to-Head

Bigger by revenue
FVCB
FVCB
1.8× larger
FVCB
$16.9M
$9.2M
CTSO
Growing faster (revenue YoY)
FVCB
FVCB
+4376.6% gap
FVCB
4377.5%
0.9%
CTSO
More free cash flow
FVCB
FVCB
$28.7M more FCF
FVCB
$23.8M
$-4.9M
CTSO
Faster 2-yr revenue CAGR
FVCB
FVCB
Annualised
FVCB
586.6%
1.3%
CTSO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTSO
CTSO
FVCB
FVCB
Revenue
$9.2M
$16.9M
Net Profit
$-5.5M
Gross Margin
73.7%
Operating Margin
-47.5%
43.7%
Net Margin
-59.5%
Revenue YoY
0.9%
4377.5%
Net Profit YoY
27.4%
EPS (diluted)
$-0.09
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTSO
CTSO
FVCB
FVCB
Q4 25
$9.2M
$16.9M
Q3 25
$9.5M
$416.0K
Q2 25
$9.6M
$15.8M
Q1 25
$8.7M
$382.0K
Q4 24
$9.2M
$378.0K
Q3 24
$8.6M
$412.0K
Q2 24
$8.8M
$415.0K
Q1 24
$9.0M
$359.0K
Net Profit
CTSO
CTSO
FVCB
FVCB
Q4 25
$-5.5M
Q3 25
$-3.2M
$5.6M
Q2 25
$1.9M
$5.7M
Q1 25
$-1.5M
$5.2M
Q4 24
$-7.6M
Q3 24
$-2.8M
$4.7M
Q2 24
$-4.3M
$4.2M
Q1 24
$-6.1M
$1.3M
Gross Margin
CTSO
CTSO
FVCB
FVCB
Q4 25
73.7%
Q3 25
70.3%
Q2 25
70.9%
Q1 25
71.1%
Q4 24
68.4%
Q3 24
61.0%
Q2 24
73.5%
Q1 24
76.5%
Operating Margin
CTSO
CTSO
FVCB
FVCB
Q4 25
-47.5%
43.7%
Q3 25
-30.2%
Q2 25
-37.6%
45.9%
Q1 25
-44.5%
Q4 24
-37.1%
Q3 24
-56.1%
Q2 24
-40.4%
Q1 24
-51.8%
Net Margin
CTSO
CTSO
FVCB
FVCB
Q4 25
-59.5%
Q3 25
-33.4%
1341.1%
Q2 25
20.2%
36.0%
Q1 25
-16.9%
1352.1%
Q4 24
-82.7%
Q3 24
-32.1%
1133.3%
Q2 24
-48.6%
1001.2%
Q1 24
-67.7%
373.3%
EPS (diluted)
CTSO
CTSO
FVCB
FVCB
Q4 25
$-0.09
$0.31
Q3 25
$-0.05
$0.31
Q2 25
$0.03
$0.31
Q1 25
$-0.02
$0.28
Q4 24
$-0.14
$0.27
Q3 24
$-0.05
$0.25
Q2 24
$-0.08
$0.23
Q1 24
$-0.11
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTSO
CTSO
FVCB
FVCB
Cash + ST InvestmentsLiquidity on hand
$6.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$5.9M
$253.6M
Total Assets
$44.2M
$2.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTSO
CTSO
FVCB
FVCB
Q4 25
$6.2M
Q3 25
$7.5M
Q2 25
$10.2M
Q1 25
$11.6M
Q4 24
$3.3M
Q3 24
$5.7M
Q2 24
$8.5M
Q1 24
$8.6M
Total Debt
CTSO
CTSO
FVCB
FVCB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$13.8M
Q2 24
$13.7M
Q1 24
$4.4M
Stockholders' Equity
CTSO
CTSO
FVCB
FVCB
Q4 25
$5.9M
$253.6M
Q3 25
$9.0M
$249.8M
Q2 25
$11.6M
$243.2M
Q1 25
$14.5M
$242.3M
Q4 24
$11.1M
$235.4M
Q3 24
$13.4M
$230.8M
Q2 24
$17.4M
$226.5M
Q1 24
$19.6M
$220.7M
Total Assets
CTSO
CTSO
FVCB
FVCB
Q4 25
$44.2M
$2.3B
Q3 25
$45.8M
$2.3B
Q2 25
$48.0M
$2.2B
Q1 25
$50.8M
$2.2B
Q4 24
$47.4M
$2.2B
Q3 24
$47.8M
$2.3B
Q2 24
$53.4M
$2.3B
Q1 24
$47.1M
$2.2B
Debt / Equity
CTSO
CTSO
FVCB
FVCB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
1.03×
Q2 24
0.78×
Q1 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTSO
CTSO
FVCB
FVCB
Operating Cash FlowLast quarter
$-4.8M
$23.9M
Free Cash FlowOCF − Capex
$-4.9M
$23.8M
FCF MarginFCF / Revenue
-53.4%
140.7%
Capex IntensityCapex / Revenue
1.2%
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-12.5M
$40.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTSO
CTSO
FVCB
FVCB
Q4 25
$-4.8M
$23.9M
Q3 25
$-2.6M
$7.6M
Q2 25
$-1.5M
$3.3M
Q1 25
$-3.5M
$5.4M
Q4 24
$-2.3M
$18.2M
Q3 24
$-2.5M
$4.7M
Q2 24
$-4.8M
$1.6M
Q1 24
$-4.8M
$7.2M
Free Cash Flow
CTSO
CTSO
FVCB
FVCB
Q4 25
$-4.9M
$23.8M
Q3 25
$-2.6M
$7.6M
Q2 25
$-1.5M
$3.3M
Q1 25
$-3.5M
$5.4M
Q4 24
$-2.4M
$18.1M
Q3 24
$-2.6M
$4.6M
Q2 24
$-4.8M
$1.5M
Q1 24
$-4.9M
$7.1M
FCF Margin
CTSO
CTSO
FVCB
FVCB
Q4 25
-53.4%
140.7%
Q3 25
-27.3%
1818.0%
Q2 25
-16.1%
20.8%
Q1 25
-39.7%
1413.6%
Q4 24
-26.3%
4786.0%
Q3 24
-30.4%
1121.8%
Q2 24
-54.4%
361.2%
Q1 24
-54.2%
1988.3%
Capex Intensity
CTSO
CTSO
FVCB
FVCB
Q4 25
1.2%
0.3%
Q3 25
0.2%
0.2%
Q2 25
0.4%
0.1%
Q1 25
0.0%
4.2%
Q4 24
0.8%
37.3%
Q3 24
1.8%
14.1%
Q2 24
0.2%
12.8%
Q1 24
0.5%
3.9%
Cash Conversion
CTSO
CTSO
FVCB
FVCB
Q4 25
Q3 25
1.36×
Q2 25
-0.78×
0.58×
Q1 25
1.05×
Q4 24
Q3 24
1.00×
Q2 24
0.37×
Q1 24
5.34×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTSO
CTSO

Direct$5.1M55%
Distributors And Strategic Partners$4.2M45%

FVCB
FVCB

Segment breakdown not available.

Related Comparisons